Search

everythinglearnresearchcommunity

for

Search:↓

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Cell-based models help test if cosmetic ingredients really work for hair growth and skin health.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Ageratum conyzoides extract promotes hair growth and regrowth.

Early androgen exposure affects hormone receptor expression in adult female rats' brains, but not in males.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Scientists created cell lines from balding patients and found that cells from the front of the scalp are more affected by hormones that cause hair loss than those from the back.

Neuroactive steroids affect cocaine's rewarding effects through the sigma1 receptor.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

A new plant extract from Avicennia marina could potentially be used to treat common hair loss.

A peptide from fermented Trapa japonica fruit may help reduce skin aging.

The Shen Bai Hair Growing Decoction may help treat hair loss by promoting hair growth and reducing inflammation.

Cells lacking the Bax protein can outcompete others, leading to better tissue repair and hair growth.

WNT10A helps esophageal cancer cells spread and keep renewing themselves.

A gene mutation in Lama3 is linked to a common type of hair loss.

Understanding molecular mediators can improve skin healing treatments.

Blocking CRF-R1 can reduce alcohol intake in stressed mice.

Injecting alpha-melanocyte-stimulating hormone in mice improved skin healing and reduced scarring.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

A reliable method was created to measure dutasteride and related molecules in capsules.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Finasteride raises suicide-linked aggression and stops clozapine's positive effects in schizophrenia animals.